Psychotropic Use in People with Intellectual Disabilities: How Evidence from the EQUIP Study can Inform and Support Policy and Practice
As part of the EQUIP Project, a webinar titled "Psychotropic Use in People with Intellectual Disabilities: How Evidence from the EQUIP Study can Inform and Support Policy and Practice" was held to disseminate the project's key findings. The event explored the implications of these findings and discussed how they can inform and shape future policy and practice to enhance health outcomes and improve the quality of life for older adults with intellectual disabilities.Psychotropic Use in People with Intellectual Disabilities: How Evidence from the EQUIP Study can Inform and Support Policy and Practice
Watch the full webinar here.
Panel Disscussion:
- Professor Mary McCarronProfessor of Ageing and Intellectual Disability, Director of the Trinity Centre for Ageing and Intellectual Disability (TCAID) and Principal investigator of IDS-TILDA
- Assistant Professor Máire O’DwyerAssistant Professor in Pharmacy and Principal Investigator of the EQUIP project
- Dr Rosemary GowranClinical Lead Health Service Executive (HSE) Clinical Programme for People with Disabilities